Kim E. Ellison
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Christopher J. Rivard (15 shared papers)Leslie M. Rozeboom (11 shared papers)Hui Yu (9 shared papers)Yayi He (4 shared papers)Fred R. Hirsch (7 shared papers)Fred R. Hirsch (10 shared papers)Rafał Dziadziuszko (6 shared papers)Kenichi Suda (10 shared papers)
- Journals
- Journal of Thoracic Oncology (5 papers)Lung Cancer (3 papers)Molecular Cancer Therapeutics (1 paper)Journal of Surgical Oncology (1 paper)Cancer Treatment Reviews (1 paper)
- Partner nations
- United StatesJapanChina
In The Last Decade
Kim E. Ellison
21 papers receiving 1k citations
Peers
Comparison fields: 5 of 47
- Oncology 671
- Pulmonary and Respiratory Medicine 214
- Immunology 80
- Cancer Research 37
- Endocrinology, Diabetes and Metabolism 41
Countries citing papers authored by Kim E. Ellison
This map shows the geographic impact of Kim E. Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim E. Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim E. Ellison more than expected).
Fields of papers citing papers by Kim E. Ellison
This network shows the impact of papers produced by Kim E. Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim E. Ellison. The network helps show where Kim E. Ellison may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim E. Ellison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 228 | |
| 2 | 2016 | 161 | |
| 3 | 2016 | 117 | |
| 4 | 2017 | 97 | |
| 5 | 2014 | 58 | |
| 6 | 2017 | 55 | |
| 7 | 2018 | 43 | |
| 8 | 2020 | 42 | |
| 9 | 2018 | 41 | |
| 10 | 2018 | 40 | |
| 11 | 2015 | 32 | |
| 12 | 2017 | 26 | |
| 13 | 2018 | 25 | |
| 14 | 2022 | 24 | |
| 15 | 2017 | 20 | |
| 16 | 2017 | 14 | |
| 17 | 2016 | 12 | |
| 18 | 2017 | 10 | |
| 19 | 2019 | 8 | |
| 20 | 1993 | 2 |
About Kim E. Ellison
Kim E. Ellison is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Gastroenterology and Statistics, Probability and Uncertainty, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (4 papers), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), interferon and immune responses (1 paper), Gastrointestinal disorders and treatments (1 paper), Fibroblast Growth Factor Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (671 citations), Pulmonary and Respiratory Medicine (214 citations), Immunology (80 citations), Cancer Research (37 citations) and Endocrinology, Diabetes and Metabolism (41 citations). Kim E. Ellison has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Christopher J. Rivard, Leslie M. Rozeboom, Hui Yu, Yayi He, Fred R. Hirsch, Fred R. Hirsch, Rafał Dziadziuszko, Kenichi Suda, Caicun Zhou and Shengxiang Ren. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Molecular Cancer Therapeutics, Journal of Surgical Oncology and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.